Table 3.
Baseline Aglietti stage I | n = 16, 43.2% |
Baseline Aglietti stage II | n = 15, 40.5% |
Baseline Aglietti stage III | n = 6, 16.3% |
n | Mean Aglietti staging | |
---|---|---|
Pre-HBOT | 37 | 1.7 ± 0.7 |
Post-HBOT | 37 | 0.3 ± 0.6a |
7 year follow up | 14 | 0.3 ± 1.0a,b |
Significant reduction from pre-HBOT staging (P < .01).
Not significantly different from post-HBOT staging (P < .01).